Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Toxie Qingfei Decoction is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Shenzhen Traditional Chinese Medicine Hospital for the treatment of COVID-19. The formula is designed based on the TCM principles of clearing heat, detoxifying the body (Qingre Jiedu), and penetrating and resolving pathogens (Toujie) to treat epidemic diseases. It is primarily utilized for patients with mild to moderate (common) COVID-19 to alleviate respiratory symptoms such as fever and cough, and to reduce the risk of disease progression to severe stages. As a complex herbal decoction, it likely exerts its therapeutic effects through multi-target pathways, including anti-inflammatory and immunomodulatory mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Toxie Qingfei Decoction.